Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Alamar Biosciences, Inc.NASDAQ: ALMR

Retained Earnings · Q2 FY2026 · quarter ended Jun 2026

Retained earnings of -$203.3M in Q2 FY2026

Q2 FY2026 retained earnings was -$203.3M.

Context

  • Retained earnings amounted to 52.0% of total assets at the end of Q2 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$203.3M-6.9% QoQ
Last fiscal yearDec 2025
-$168.78M-21.5% YoY
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-21.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(168.78M) USD
Year-over-year change
-21.5%

Retained Earnings vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's Jun 2026 retained earnings of -$203.3M is the 2nd highest of the 9 companies compared; the peer median is -$926.57M.
  • Retained earnings amounts to 52.0% of total assets for ALMR, versus a peer median of 177.4%.
ALMR Competitors Peer median
Retained Earnings for ALMR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TECHBio-Techne CorporationSep 2026$1.15B +6.5%-4.4%43.7%
ALMRAlamar Biosciences, Inc.Jun 2026-$203.3M ——52.0%
NAUTNautilus Biotechnology, Inc.Mar 2026-$346.72M -19.7%—195.0%
SEERSeer, Inc.Mar 2026-$482.81M -17.1%—177.4%
QSIQuantum-Si incorporatedMar 2026-$719.65M -16.9%—337.3%
LABStandard BioTools Inc.Mar 2026-$1.13B +6.5%—177.4%
TWSTTwist Bioscience CorporationSep 2026-$1.45B -9.9%—129.2%
TXG10x Genomics, Inc.Sep 2026-$1.56B -4.5%—146.9%
PACBPacific Biosciences of California, Inc.Mar 2026-$2.7B -5.0%—345.6%
Peer median (excluding ALMR) -$926.57M-7.4%-4.4%177.4%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.